112 related articles for article (PubMed ID: 18797208)
1. Hematologic complications of hepatitis A: another reason for implementation of anti-HAV vaccination.
Chatzimichael A; Schoina M; Arvanitidou V; Ramatani A; Mantadakis E
J Pediatr Hematol Oncol; 2008 Jul; 30(7):562. PubMed ID: 18797208
[No Abstract] [Full Text] [Related]
2. [Hepatitis and aplastic anemia].
Timmermans U; Waumans P
Ned Tijdschr Geneeskd; 1970 Feb; 114(7):286-90. PubMed ID: 5414196
[No Abstract] [Full Text] [Related]
3. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
[TBL] [Abstract][Full Text] [Related]
5. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
[TBL] [Abstract][Full Text] [Related]
7. [Risks associated with hepatitis infection in patients with hepatitis C and opportunities for prophylaxis].
Chlabicz S
Przegl Epidemiol; 2003; 57(3):465-70. PubMed ID: 14682165
[TBL] [Abstract][Full Text] [Related]
8. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis A: disease burden and current childhood vaccination strategies in the United States.
Koslap-Petraco MB; Shub M; Judelsohn R
J Pediatr Health Care; 2008; 22(1):3-11. PubMed ID: 18174084
[TBL] [Abstract][Full Text] [Related]
10. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
Myers RP; Gregor JC; Marotta PJ
Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
13. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
[TBL] [Abstract][Full Text] [Related]
14. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
15. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?
Hernandez B; Hasson NK; Cheung R
Am J Gastroenterol; 2009 Aug; 104(8):1961-7. PubMed ID: 19491840
[TBL] [Abstract][Full Text] [Related]
17. [Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy].
Bruguera M; Salleras L; Plans P; Vidal J; Navas E; Domínguez A; Batalla J; Taberner JL; Espuñes J
Med Clin (Barc); 1999 Mar; 112(11):406-8. PubMed ID: 10231772
[TBL] [Abstract][Full Text] [Related]
18. [Hematologic complications of viral hepatitis. A fatal case pancytopenia with abnormal karyotype].
Albahary C; de Grouchy J; Turleau C; Auffret M; Martin S; Leger B
Presse Med (1893); 1971 May; 7(23):1055-8. PubMed ID: 5103730
[No Abstract] [Full Text] [Related]
19. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
Bryan JP; Nelson M
Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
